Research Article
Can Preoperative Examination Help Choose the Best Surgical Procedure in Gastric Cancer?
Table 2
Preoperative examination results of the beyond perigastric group and the perigastric group.
| | Beyond perigastric | Perigastric |
| | HGB (g/L) | 123.11 ± 2.21 | 130.44 ± 1.64 | | GRAN (109/L) | 3.68 ± 0.15 | 3.63 ± 0.09 | | Lymphocytes (109/L) | 2.23 ± 0.19 | 1.78 ± 0.13 | | WBC (109/L) | 6.21 ± 0.17 | 6.31 ± 0.13 | | PLT (109/L) | 242.67 ± 5.42 | 233.54 ± 4.91 | | CA19-9 (U/mL) | 64.61 ± 15.01 | 30.54 ± 6.74 | | CEA (ng/mL) | 11.15 ± 2.35 | 2.48 ± 0.18 | | AFP (U/mL) | 10.84 ± 6.41 | 5.10 ± 1.97 | | CA12-5 (U/mL) | 14.06 ± 0.87 | 14.65 ± 1.23 | | CA15-3 (U/mL) | 8.67 ± 0.46 | 9.32 ± 0.51 | | Age | 58.26 ± 0.87 | 58.94 ± 0.69 | | Sex | | | | Male | 98 | 177 | | Female | 43 | 60 | | CT examination | | | | Positive | 173 | 19 | | Negative | 63 | 123 | | cT stage | | | | cT1–cT3 | 44 | 84 | | cT4 | 110 | 140 | | Tumor site | | | | Upper 1/3 | 15 | 29 | | Middle 1/3 | 20 | 54 | | Lower 1/3 | 100 | 150 | | Occupy more than 2 areas | 6 | 4 | | Tumor size | | | | >5 cm | 70 | 70 | | <5 cm | 71 | 167 | | Differentiated types | | | | Undifferentiated type | 109 | 144 | | Differentiated type | 32 | 93 | | Borrmann types | | | | Localizable group | 9 | 25 | | Infiltrative group | 128 | 145 |
|
|
